KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Taxes (2021 - 2024)

Historic Change in Taxes for Moderna (MRNA) over the last 4 years, with Q3 2024 value amounting to -$2.0 million.

  • Moderna's Change in Taxes fell 12222.22% to -$2.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$51.0 million, marking a year-over-year decrease of 41000.0%. This contributed to the annual value of $15.0 million for FY2023, which is 10181.16% up from last year.
  • Latest data reveals that Moderna reported Change in Taxes of -$2.0 million as of Q3 2024, which was down 12222.22% from -$45.0 million recorded in Q2 2024.
  • Over the past 5 years, Moderna's Change in Taxes peaked at $716.0 million during Q1 2022, and registered a low of -$1.2 billion during Q2 2022.
  • For the 4-year period, Moderna's Change in Taxes averaged around $333333.3, with its median value being $7.0 million (2023).
  • Data for Moderna's Change in Taxes shows a peak YoY increase of 69555.56% (in 2022) and a maximum YoY decrease of 53310.1% (in 2022) over the last 5 years.
  • Quarter analysis of 4 years shows Moderna's Change in Taxes stood at $311.0 million in 2021, then plummeted by 105.79% to -$18.0 million in 2022, then surged by 138.89% to $7.0 million in 2023, then crashed by 128.57% to -$2.0 million in 2024.
  • Its Change in Taxes was -$2.0 million in Q3 2024, compared to -$45.0 million in Q2 2024 and -$11.0 million in Q1 2024.